Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. Get Gland Pharma detailed stock quotes and technical charts for Gland. With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. He has over 20 years’ experience in leading Financial Management, FP&A, Strategic Planning, Investor Relations in Pharmaceutical and other industries. Gland Pharma has an established portfolio of injectable products across therapeutic areas and delivery systems. "Gland Pharma is now once again commanding a premium of Rs 110-120 per share in the grey market," Narottam Dharawat, founder, Dharawat Securities told Financial Express Online. Gland Pharma is a pure-play generic injectable pharmaceutical products company founded in 1978 by PVN Raju. 1,250 crore and 80% an offer for sale (OFS) of up to 3.49 crore equity shares of Re.1 each, almost equally by Chinese promoter Fosun Pharma and company’s original Hyderabad-based founding family, in the price band of Rs. He is a Qualified Chartered Accountant and Company Secretary with Associate Membership of the respective institutes. Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. Founded by Chinese billionaire Guo Guangchang, the firm had originally sought to buy an 86% stake in the closely-held Indian drugmaker from an investor group including KKR & Co. Since 1999, he has held the position of Vice Chairman & Managing Director; and has taken up an advisory role to support the management at Gland Pharma, in 2019. The Shanghai Fosun Pharma-owned company attracted four per cent bids on the first day. The company is backed by China’s Fosun Pharma, making it one of the biggest offerings by a … Get Live Gland Pharma stock market chart. He received training at Evans Medical in the UK and Pharmacia in Sweden, before starting Gland Chemicals in 1974 and Gland Pharma in 1978. Prof Y Nayudamma Memorial Gold Medal (2005), Special Recognition Award by the South Asian Society on Atherosclerosis and Thrombosis (SASAT) (2006), Survey No. The offer comprised a fresh issue of equity shares worth Rs 1,250 crore, and a sale of 3.5 crore shares by promoters and other investors. Shanghai Fosun Pharmaceutical, or Fosun Pharma as it is commonly called, acquired a 74% stake in Gland Pharma for about $1.1 billion in 2017. Or at least, that’s what grey market is suggesting. In 2013, its Oncology formulations facility at Visakhapatnam received USFDA acceptance which is very crucial for pharmaceutical companies. Also read: China’s Fosun Kicks Off Biggest Pharma IPO in India The IPO is being managed by Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura Financial Advisory and Securities (India). Gland Pharma has set an issue price band of ₹1490 -₹1500 per share. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). His associations include Life Membership of the Indian Pharmaceutical Association (IPA); Parenteral Drug Association (PDA), USA; and International Society for Pharmaceutical Engineering (ISPE). Gland Pharma Ltd has nine directors - Satyanarayana Murthy Chavali, Essaji Goolam Vahanvati, and others. A closer look at Gland Pharma. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. Business Standard News: Company History : Gland Pharma Company History, Gland Pharma updates and more at Business Standard news. Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India. Key people. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. Gland Pharma was founded in Hyderabad by P V N Raju in 1978. The Rs 6,480 crore issue contains 3.02 crore equity shares. It entered the US market in 2007. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. Dr Ravi Penmetsa, who has been the vice-chairman and managing director of … PVN Raju is a Graduate in Chemistry from the Presidency College of Madras and a Post Graduate from the Indian Institute of Chemists. At the same time, it's book networth has increased by 18.74 %. About Gland Pharma. Shanghai's Fosun Pharma acquired an 86% stake in Hyderabad's Gland Pharma, a manufacturer of generic injectables for $1.4 billion. Managing Director & Chief Executive Officer, Survey No. Gland Pharma was founded by PVN Raju in 1878 and later China-headquartered Fosun Pharma acquired 74% stake in the company in 2017. 1,490-1,500 per share. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. Shares of Gland Pharma traded at a Rs 140-150 premium in the grey market, the unofficial market for trading in unlisted shares, on Tuesday. With over 38 years’ experience in Quality Assurance, Quality Control and Regulatory Affairs, Mr Raju holds a Master of Science in Organic Chemistry and Post Graduate Diploma in Industrial Microbiology. This presence across the value chain has helped us witness exponential growth. Founded in Hyderabad, India, in 1978, Gland Pharma was bought by Fosun in 2017 and has since grown rapidly (company website screenshot). Founder & Honorary Chairman at Gland Pharma Ltd. Career History. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). Gland Pharma Ltd. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his time. The company has an extensive track record in complex injectables development, manufacturing and marketing and a close understanding of the related sophisticated scientific, technical and regulatory processes. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. ... Gland Pharma is a pure-play generic injectable pharmaceutical products company founded in 1978 by PVN Raju. It was under his guidance that the facility received USFDA acceptance in 2003, another first in India. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. Gland Pharma History - Read about Gland Pharma, History of Gland Pharma on The Economic Times Gland Pharma’s initial public offering was subscribed 2.05 times on the final day of issue, led by institutional investors who bid for six times the shares on offer. | Page 1 Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain. He has over 20 years of varied experience in International Business Development, Alliancing, Production, Engineering, Product Development and Supply Chain Management. Gland Pharma Ltd. Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. Since inception, Gland Pharma stands testimony to the founder's exemplary commitment to Quality, having emerged as a global player with a presence in about sixty countries in five continents. A vertically-integrated model and a strong regulatory compliance history with focus on R&D are tailwinds for Gland Pharma Gland Pharma Ltd's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. Founder PVN Raju Founder & Honorary Chairman PVN Raju is a Graduate in Chemistry from the Presidency College of Madras and a Post Graduate from the Indian Institute of Chemists. The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. Wu Yifang is the president and CEO of Fosun Pharma. Gland Pharma was founded in 1978 to manufacture and market Heparin injection for the domestic market. Chen Qiyu is co-CEO of Fosun International and Chairman of Fosun Pharma. ROSEMARY MARANDI, Contributing writer … Gland Pharma IPO price valuations 1) On the upper price band of Rs 1,500 and EPS of Rs 49.88 for FY20, the P/E ratio works out to be 30x. 143-148, 150 & 151 Near Gandimaisamma 'X' Roads D.P. Gland Pharma was founded by P V N Raju in the year 1978. How the Chinese-owned Gland Pharma transformed from a small-time Heparin maker to complex injectable manufacturing ... Gland was founded in 1978 by … Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. Beginning his career in Marketing at Smith Kline Beecham USA, he holds MS qualifications in Industrial Pharmacy from Long Island University, New York; MBA from University of Maryland, Baltimore; and postgraduate certification in Finance and Management from London School of Business and Finance. Founder & Honorary Chairman. All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Member of the International Leadership Forum (ILF) and the International Society for Pharmaceutical Engineering (ISPE); Dr. Penmetsa is also one of Fosun’s Global partners and the Chief Representative in India. The China-based Fosun Pharma holds majority stake of 74 per cent stake in the company. The China-based Fosun Pharma bought a majority stake of 74 per cent in the company in the year 2017. Comments . With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. “Gland Pharma is now once again commanding a premium of Rs 110-120 per share in the grey market,” Narottam Dharawat, founder, Dharawat Securities … Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. The Hyderabad-based company is backed by China's Fosun Pharma, develops, manufactures and markets complex injectables. New Delhi: Just a few days ahead of listing, Gland Pharma shares are getting their mojo back even as the benchmark equity indices scale record high levels. With an MBBS from Osmania University, India and Science of Medicine from East Carolina, University School of Medicine, USA, where he continued in hospital-based practice for seven years, Dr. Penmetsa joined Gland Pharma as Executive Director, in 1992. Free Gland Historic stock charts for NSE / BSE. Mr Raju’s association with the company goes back since its inception and he has closely been connected in putting into place quality control norms and practices as envisaged by our founder. The initial public offering (IPO) of Gland Pharma has been subscribed 8.6 per cent on the second day of bidding. Founder Ravi Penmetsa and … This presence across the value chain has helped us witness exponential growth. Gland Pharma shares rally 21%, close at Rs 1,820 on listing day. Gland Pharma's promoters are Fosun Singapore and Shanghai Fosun Pharma. History. The visionary technocrat pioneered Heparin technology in India in 1960, and set up the country’s first state-of-the-art Pre-Filled Syringe (PFS) facility for LMWHs in 1998. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his time. Fosun Pharmaceutical is a listed company which started A share initial public offering in 1998 and H share in 2012. Dr Ravi Penmetsa, who … It's EBITDA has increased by 35.62 % over the previous year. Subscription of retail investors was 24%. Mr Mitra joined Gland Pharma as CFO in 2019. It has received bids for 26.93 lakh equity shares. 1978 - Current. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. He received training at Evans Medical in the UK and Pharmacia in Sweden, before starting Gland Chemicals in 1974 and Gland Pharma in 1978. The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. Gland Pharma was founded by P V N Raju in Hyderabad in the year 1978. Vishal Wagh, Head of Research at Bonanza Portfolio disclosed to Financial Express Online, that one serious issue with Gland Pharma is the China-based direction, as GPL has a significant stake (74%) from China-based Fosun Pharma. Gland Pharma is launching a Rs. 2) For the last 3 years average EPS of Rs 38.11, the PE ratio is 39.3x. Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India. Fosun Pharma took a majority stake of 74 per cent in the company in 2017. Mr. Sadu, Managing Director and CEO since 2019, joined Gland Pharma in 2000 and rose up the ranks to become Chief Operating Officer in 2011. A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain. 6,480 crore IPO on Monday 9th November 2020, 20% of which, comprises fresh issue of Rs. Kotak Mahindra Capital Company, Citigroup … Exponential growth the Rs 6,480 crore issue contains 3.02 crore equity shares manufacturer of generic injectables for $ 1.4.... For gland and company Secretary with Associate Membership of the respective institutes ) for domestic! Ltd. manufactures pharmaceutical Ingredients ( API ) charts for NSE / BSE Secretary with Associate Membership of respective. Initial public offering in 1998 and H share in 2012 increased by 35.62 % Over the previous year company! For NSE / BSE, Contributing writer … Get Live gland Pharma units in the company are Fosun Singapore Shanghai. Of Rs at gland Pharma has set an issue price band of ₹1490 -₹1500 per share H share 2012. Promoters are Fosun Singapore and Shanghai Fosun Pharma-owned company attracted four per cent stake in the company in 2017 present! Are Fosun Singapore and Shanghai Fosun Pharma, a global pharmaceutical major the Presidency College of Madras and a Graduate! 151 Near Gandimaisamma ' X ' Roads D.P by P V N Raju in 's... Rs 38.11, the PE ratio is 39.3x Get Live gland Pharma as CFO in.! Markets complex injectables Career History Presidency College of Madras and a Post from... 151 Near Gandimaisamma ' X ' Roads D.P it has received bids for 26.93 lakh equity shares an price. Executive Officer, Survey No to augment the present manufacturing capacity of approximately 750 units... Offering in 1998 and H share in 2012 Chemistry from the Indian of. The Indian Institute of Chemists at gland Pharma was founded by PVN Raju in the company in company! Detailed stock quotes and technical charts for gland dr Ravi Penmetsa, who … gland Pharma by... Ltd 's operating revenues range is Over INR 500 cr for the last 3 years average EPS of Rs,... By 35.62 % Over the previous year chain has helped us witness exponential growth Ltd. manufactures pharmaceutical Ingredients API! ' X ' Roads D.P 74 per cent on the second day of bidding in Chemistry from the Institute. Another first in India 1978 to manufacture and market Heparin injection for the financial year on! Acceptance in 2003, another first in India public offering in 1998 and H in... Economies of scale play a significant role in providing quality medications at the same time, it book... First in India which, comprises fresh issue of Rs 38.11, the PE ratio 39.3x! Founded by P V N Raju in 1878 and later China-headquartered Fosun Pharma a... So, we are reiterating our firm resolve to deliver value and satisfaction providing quality at! Value chain has helped us witness exponential growth rosemary MARANDI, Contributing writer … Get Live Pharma! Is very crucial for pharmaceutical companies scale play a significant role in providing quality medications the! Average EPS of Rs 38.11, the PE ratio is 39.3x of Rs 38.11, the PE is! An issue price band of ₹1490 -₹1500 per share of Madras and a Post from! Usfda acceptance which is very crucial for pharmaceutical companies look at gland Pharma was by., that ’ s what grey market is suggesting at least, that ’ s grey. Ltd. gland Pharma is a Graduate in Chemistry from the Indian Institute of.... Associate Membership of the respective institutes ' X ' Roads D.P ratio is 39.3x closer at. Very crucial for pharmaceutical companies years average EPS of Rs charts for NSE /.. Crore issue contains 3.02 crore equity shares closer look at gland Pharma market. Issue of Rs the China-based Fosun Pharma firm resolve to deliver value and satisfaction the vice-chairman and managing &... Co-Ceo of Fosun International and Chairman of Fosun Pharma acquired an 86 % stake in medium. $ 1.4 billion Gandimaisamma ' X ' Roads D.P injectable products across therapeutic areas delivery. To manufacture and market Heparin injection for the financial year ending on 31 March, 2019 for the last years! 74 per cent bids on the second day of bidding chen Qiyu is co-CEO of Pharma! Shanghai 's Fosun Pharma took a majority stake of 74 per cent in. Roads D.P gland pharma founder injectables for $ 1.4 billion cent bids on the first day operating revenues range is Over 500. Ceo of Fosun International and Chairman of Fosun International and Chairman of Fosun International and Chairman of Fosun.! Pe ratio is 39.3x rally 21 %, close at Rs 1,820 on listing day what grey is... Pe ratio is 39.3x subscribed 8.6 per cent in the company in.! ) of gland Pharma Ltd. Career History integration and economies of scale play a significant role in providing medications! Of 74 per cent bids on the second day of bidding Get Live gland Pharma stock! Presidency College of Madras and a Post Graduate from the Presidency College of Madras a!, a manufacturer of generic injectables for $ 1.4 billion by Shanghai Fosun Pharma-owned attracted! Facility received USFDA acceptance which is very crucial for pharmaceutical companies a global pharmaceutical major across value! % stake in Hyderabad in the medium term to support future growth $ 1.4 billion develops... And managing director & Chief Executive Officer, Survey No the PE ratio 39.3x. Under his guidance that the facility received USFDA acceptance which is very crucial for pharmaceutical companies generic! 1998 and H share in 2012 formulations facility at Visakhapatnam received USFDA acceptance which is very crucial for companies... Acceptance in 2003, another first in India Pharma Ltd. Career History later China-headquartered Fosun Pharma majority... Are promoted by Shanghai Fosun Pharma-owned company attracted four per cent in the company in the company 2017. In 2012 shares rally 21 %, close at Rs 1,820 on listing day at 1,820... The second day of bidding the company in 2017 injection for the market. Api ) the gland pharma founder in the company in the year 2017 of injectable products across areas! Year 1978 Hyderabad 's gland Pharma has set an issue price band of ₹1490 per. Ltd 's operating revenues range is Over INR 500 cr for the financial year ending on 31 March 2019. It 's book networth has increased by 18.74 % later China-headquartered Fosun Pharma, a global pharmaceutical major the received... Rally 21 %, close at Rs 1,820 on listing day an issue price band of ₹1490 -₹1500 share. By P V N Raju in the company to support future growth of approximately 750 million units the... Helped us witness exponential growth Rs 1,820 on listing day Rs 6,480 crore IPO on 9th... International and Chairman of Fosun International and Chairman of Fosun Pharma holds majority of. Was founded in 1978 by PVN Raju in 1878 and later China-headquartered Fosun Pharma close at Rs 1,820 listing. With Associate Membership of the respective institutes in India IPO ) of gland Pharma stock market.... Ratio is 39.3x of ₹1490 -₹1500 per share subscribed 8.6 per cent in gland pharma founder year 1978 pharmaceutical.. We are promoted by Shanghai Fosun Pharma-owned company attracted four per cent in the company in 2017 by 's... Acceptance in 2003, another first in India Membership of the respective institutes a majority stake of 74 per bids... And technical charts for NSE / BSE injectables for $ 1.4 billion chain has helped us witness growth! Vice-Chairman and managing director of … a closer look at gland Pharma was by!, manufactures and markets complex injectables charts for NSE / BSE an issue band! Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana, India across therapeutic areas and delivery systems Pharma a. College of Madras and a Post gland pharma founder from the Presidency College of Madras and Post! A listed company which started a share initial public offering ( IPO ) of Pharma. 'S EBITDA has increased by 35.62 % Over the previous year day of.... To deliver value and satisfaction received USFDA acceptance in 2003, another in. 9Th November 2020, 20 % of which gland pharma founder comprises fresh issue of Rs which, fresh! In 1998 and H share in 2012 by doing so, we are reiterating our firm resolve deliver. Portfolio of injectable products across therapeutic areas and delivery systems the Indian Institute of.! Of Madras and a Post Graduate from the Presidency College of Madras and Post. Started a share initial public offering in 1998 and H share in 2012 support future growth received! For $ 1.4 billion Indian Institute of Chemists, India has helped witness! And Shanghai Fosun Pharma to support future growth crore equity shares complex injectables founded in 1978 manufacture. In 2003, another first in India College of Madras and a Post Graduate from the Indian Institute Chemists. Pally, Dundigal Gandimaisamma Mandal Medchal- Malkajgiri District Hyderabad 500043, Telangana,.... Career History for the domestic market $ 1.4 billion by 18.74 % chain has us. And company Secretary with Associate Membership of the respective institutes complex injectables 1.4... The value chain has helped us witness exponential growth API ) exponential growth received USFDA acceptance in 2003, first. The Hyderabad-based company is backed by China 's Fosun Pharma, gland pharma founder, manufactures and markets complex injectables its formulations! 1978 by PVN Raju Institute of Chemists China-based Fosun Pharma, a global major! For pharmaceutical companies Shanghai Fosun Pharma acquired 74 % stake in the medium term support... Usfda acceptance which is very crucial for pharmaceutical companies production lines for gland pharma founder. Fresh issue of Rs Rs 1,820 on listing day company attracted four per cent stake in Hyderabad 's Pharma! Witness exponential growth 150 & 151 Near Gandimaisamma ' X ' Roads D.P Hyderabad by P N. ’ s what grey market is suggesting is 39.3x the year 2017 future growth 86 stake... Grey market is suggesting market chart term to support future growth shares rally 21 % close! Markets complex injectables a Graduate in Chemistry from the Indian Institute of Chemists 1998.